In the News
A new biotech company co-founded by CRISPR pioneer Jennifer Doudna is developing a device that uses CRISPR to detect all kinds of diseases like malaria, tuberculosis, and Zika... These CRISPR-based diagnostic tools have the potential to revolutionize how we test for diseases in the hospital, or even at home.
- Alessandra Potenza
Mammoth Biosciences promises to offer unprecedented disease diagnostics, using CRISPR to detect biomarkers associated with practically any disease. Co-founded by Jennifer Doudna, one of the two researchers who first put the revolutionary tool on the map, Mammoth has branded itself as the world’s first CRISPR-powered diagnostic platform, offering high-tech disease detection via at-home tests.
- Dyllan Furness
While the diagnostic element is big for the company, Mammoth is positioning itself as the platform for an “infinite number of tests” that the company and its partners could run. And while cancer is a massive application for CRISPR, the technology isn’t limited to health. Martin notes that it could be used in something like agriculture to identify a soil biome or to crack a forensic case gone cold.
- Taylor Hatmaker
Called Mammoth Biosciences, the startup is developing point-of-care diagnostic tests that work by using Crispr to pick up bits of genetic material circulating in your blood, spit, or urine—say, a few copies of Zika virus left behind by a mosquito, or some mutations in a cancer cell shed from a tumor.
- Megan Molteni
[Mammoth's] first goal is to create a rapid, affordable, and easy-to-use detection strip similar to an at-home pregnancy test that could be administered both within a clinical setting or elsewhere.
- Heather Mack
Biotech company Mammoth Biosciences is working on a simple, portable test that would give everyone, from healthcare professionals to just people at home, the ability to detect various diseases, infections and cancers quickly and easily.